An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
In a new strategy for preventing heart attacks and strokes, leading cardiologists are urging their fellow physicians to focus on reducing the LDL cholesterol of patients at greatest risk of suffering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results